Clinical Trials Logo

Clinical Trial Summary

This is a Phase III study about the effects of the addition of polychemotherapy to adjuvant radiotherapy in the treatment of non-metastatic uterine sarcomas.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00162721
Study type Interventional
Source Gustave Roussy, Cancer Campus, Grand Paris
Contact Patricia Pautier, Dr
Phone 33 1 42 11 4340
Email pautier@igr.fr
Status Recruiting
Phase Phase 3
Start date September 2001

See also
  Status Clinical Trial Phase
Completed NCT02096783 - Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Cancer N/A
Completed NCT01806350 - Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors N/A
Recruiting NCT05881967 - Molecular Mechanism Study of Uterine Sarcoma
Active, not recruiting NCT06244251 - Comparison Between Laparoendoscopic Single-site Surgery and Multi-port Laparoscopy in Treating Uterine Fibroids N/A
Completed NCT00020267 - Vaccine Therapy in Treating Patients With Metastatic Cancer Phase 1
Recruiting NCT04224467 - The Application of Real-Time Near-infrared Imaging in Gynecological Surgery N/A
Active, not recruiting NCT01979393 - IRCI Gynae Sarcomas, High Grade Uterine Sarcoma Phase 2
Completed NCT01303094 - Continuing vs Intermittent Trabectedin in Patients With Advanced Soft Tissue Sarcoma Phase 2
Available NCT03493165 - Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)